The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Research Report 2025
Synopsis
The field of contract research and manufacturing broadly encompasses those services in the pharmaceutical and biotechnology sectors that require extensive research and development and large-scale manufacturing facilities.
The global Pharmaceutical Contract Research and Manufacturing (CRAM) market was valued at US$ 209390 million in 2023 and is anticipated to reach US$ 380540 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Research and Manufacturing (CRAM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Research and Manufacturing (CRAM).
Report Scope
The Pharmaceutical Contract Research and Manufacturing (CRAM) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Research and Manufacturing (CRAM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Research and Manufacturing (CRAM) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim International GmbH
Catalent, Inc
IQVIA
Lonza
Thermo Fisher Scientific Inc.
Segment by Type
Contract Research Organizations (CRO)
Contract Manufacturing Organizations (CMO)
Segment by Application
Pharmaceutical
Biotechnology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Research and Manufacturing (CRAM) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The field of contract research and manufacturing broadly encompasses those services in the pharmaceutical and biotechnology sectors that require extensive research and development and large-scale manufacturing facilities.
The global Pharmaceutical Contract Research and Manufacturing (CRAM) market was valued at US$ 209390 million in 2023 and is anticipated to reach US$ 380540 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Research and Manufacturing (CRAM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Research and Manufacturing (CRAM).
Report Scope
The Pharmaceutical Contract Research and Manufacturing (CRAM) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Contract Research and Manufacturing (CRAM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Research and Manufacturing (CRAM) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim International GmbH
Catalent, Inc
IQVIA
Lonza
Thermo Fisher Scientific Inc.
Segment by Type
Contract Research Organizations (CRO)
Contract Manufacturing Organizations (CMO)
Segment by Application
Pharmaceutical
Biotechnology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Research and Manufacturing (CRAM) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Contract Research Organizations (CRO)
1.2.3 Contract Manufacturing Organizations (CMO)
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Perspective (2019-2030)
2.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Contract Research and Manufacturing (CRAM) Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Dynamics
2.3.1 Pharmaceutical Contract Research and Manufacturing (CRAM) Industry Trends
2.3.2 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Drivers
2.3.3 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Challenges
2.3.4 Pharmaceutical Contract Research and Manufacturing (CRAM) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Research and Manufacturing (CRAM) Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Research and Manufacturing (CRAM) Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Research and Manufacturing (CRAM) Revenue
3.4 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Research and Manufacturing (CRAM) Revenue in 2023
3.5 Pharmaceutical Contract Research and Manufacturing (CRAM) Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Research and Manufacturing (CRAM) Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Research and Manufacturing (CRAM) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Research and Manufacturing (CRAM) Breakdown Data by Type
4.1 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Contract Research and Manufacturing (CRAM) Breakdown Data by Application
5.1 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Contract Research and Manufacturing (CRAM) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size (2019-2030)
6.2 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size (2019-2030)
7.2 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size (2019-2030)
9.2 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Contract Research and Manufacturing (CRAM) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Contract Research and Manufacturing (CRAM) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Company Detail
11.1.2 Boehringer Ingelheim International GmbH Business Overview
11.1.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Research and Manufacturing (CRAM) Introduction
11.1.4 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Research and Manufacturing (CRAM) Business (2019-2024)
11.1.5 Boehringer Ingelheim International GmbH Recent Development
11.2 Catalent, Inc
11.2.1 Catalent, Inc Company Detail
11.2.2 Catalent, Inc Business Overview
11.2.3 Catalent, Inc Pharmaceutical Contract Research and Manufacturing (CRAM) Introduction
11.2.4 Catalent, Inc Revenue in Pharmaceutical Contract Research and Manufacturing (CRAM) Business (2019-2024)
11.2.5 Catalent, Inc Recent Development
11.3 IQVIA
11.3.1 IQVIA Company Detail
11.3.2 IQVIA Business Overview
11.3.3 IQVIA Pharmaceutical Contract Research and Manufacturing (CRAM) Introduction
11.3.4 IQVIA Revenue in Pharmaceutical Contract Research and Manufacturing (CRAM) Business (2019-2024)
11.3.5 IQVIA Recent Development
11.4 Lonza
11.4.1 Lonza Company Detail
11.4.2 Lonza Business Overview
11.4.3 Lonza Pharmaceutical Contract Research and Manufacturing (CRAM) Introduction
11.4.4 Lonza Revenue in Pharmaceutical Contract Research and Manufacturing (CRAM) Business (2019-2024)
11.4.5 Lonza Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Detail
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Research and Manufacturing (CRAM) Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Research and Manufacturing (CRAM) Business (2019-2024)
11.5.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
